Similar articles

• Are we closer to the prevention of HPV-related diseases?

  Harper DM. Harper DM. J Fam Pract. 2005 Jul;Suppl HPV Prevention:S10-6; quiz S23. J Fam Pract. 2005. PMID: 16093008 Review. No abstract available.
• Human papillomavirus infection among sexually active young women in the United States: Implications for developing a vaccination strategy.

  Manhart LE, Holmes KK, Koutsky LA, Wood TR, Kenney DL, Feng Q, Kiviat NB. Manhart LE, et al. Sex Transm Dis. 2006 Aug;33(8):502-8. doi: 10.1097/01.olq.0000204545.89516.0a. Sex Transm Dis. 2006. PMID: 16572039
• Human papillomavirus vaccination: expected impacts and unresolved issues.

  Dempsey AF, Freed GL. Dempsey AF, et al. J Pediatr. 2008 Mar;152(3):305-9. doi: 10.1016/j.jpeds.2007.09.052. J Pediatr. 2008. PMID: 18280831 Review. No abstract available.
• Overcoming barriers to HPV vaccine acceptance.

  Mayneux EJ Jr. Mayneux EJ Jr. J Fam Pract. 2005 Jul;Suppl HPV Prevention:S17-22; quiz S23. J Fam Pract. 2005. PMID: 16093009 Review. No abstract available.
• [Knowledge of HPV-related genital lesions and of anti-HPV vaccination in a sample of women of north-eastern Italy].

  Sopracordevole F, Cigolot F, Lucia E, Marchesoni D. Sopracordevole F, et al. Minerva Ginecol. 2009 Apr;61(2):81-7. Minerva Ginecol. 2009. PMID: 19255555 Italian.